secwatch.observer — SEC 8-K summary
======================================

Issuer:     LifeStance Health Group, Inc. (LFST)
CIK:        0001845257
Form:       8-K
Filed at:   2023-03-08T23:59:59+00:00
Accession:  0000950170-23-006541
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LifeStance Q4 revenue $229.4M (+21% YoY); net loss $46.7M; 2023 rev guidance $980M-$1.02B
--------------------------------------------------------------------------------

- Q4 revenue $229.4M (+21% YoY), full year revenue $859.5M (+29% YoY).
- Q4 net loss $46.7M, full year net loss $215.6M; adjusted EBITDA Q4 $10.2M (4.4% margin), full year $52.7M (6.1% margin).
- Clinician base grew 18% to 5,631; added 200 net clinicians in Q4.
- 2023 guidance: revenue $980M-$1.02B, Center Margin $270-290M, Adjusted EBITDA $50-62M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845257/000095017023006541/0000950170-23-006541-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845257/000095017023006541/lfst-20230308.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-006541

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer